Director at Elevance Health (ELV) receives 563 deferred stock units as board compensation

Rhea-AI Filing Summary

STRABLE-SOETHOUT DEANNA D reported acquisition or exercise transactions in this Form 4 filing.

Elevance Health, Inc. director Deanna D. Strable-Soethout received a grant of 563 deferred stock units of common stock as part of the company’s Board of Directors Compensation Program. The award was at no cash cost per unit and brings her reported deferred stock unit holdings to 2,209.

The deferred stock units will be settled in Elevance Health common stock upon the earlier of five years from the grant date or when she ceases to be a board member, unless she has elected a later payout date under the Board of Directors Deferred Compensation Plan.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider STRABLE-SOETHOUT DEANNA D

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	563	$0.00	--

Holdings After Transaction: Common Stock — 2,209 shares (Direct, null)

Footnotes (1)

1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Key Figures

Deferred stock units granted: 563 units Reported deferred stock unit holdings: 2,209 units Grant price per unit: $0.0000 per unit +1 more

4 metrics

Deferred stock units granted 563 units Board compensation grant on 2026-05-13

Reported deferred stock unit holdings 2,209 units Total after 563-unit award

Grant price per unit $0.0000 per unit Equity award, no cash paid

Payout timing Earlier of 5 years or board departure Settlement schedule for deferred stock units

Key Terms

Deferred stock units, Board of Directors Compensation Program, Board of Directors Deferred Compensation Plan

3 terms

Deferred stock units financial

"Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Board of Directors Compensation Program financial

"Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program."

Board of Directors Deferred Compensation Plan financial

"unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

STRABLE-SOETHOUT DEANNA D

(Last) (First) (Middle)

220 VIRGINIA AVENUE

(Street)

INDIANAPOLIS INDIANA 46204

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/13/2026		A		563(1)(2)	A	$0	2,209	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

2. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Remarks:

	/s/ Kathleen S. Kiefer, Attorney in fact	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Elevance Health (ELV) report for Deanna Strable-Soethout?

Elevance Health (ELV) reported that director Deanna D. Strable-Soethout received 563 deferred stock units of common stock. These units were granted as part of the company’s Board of Directors Compensation Program with no cash paid per unit.

How many Elevance Health (ELV) deferred stock units does the director hold after this grant?

After this grant, Deanna D. Strable-Soethout is reported as holding 2,209 deferred stock units tied to Elevance Health common stock. This total includes the new 563-unit award under the Board of Directors Compensation Program.

Was cash paid for the 563 deferred stock units granted by Elevance Health (ELV)?

No cash was paid for the 563 deferred stock units granted to the director. The Form 4 lists a price of $0.0000 per unit, indicating this was a compensation-related equity award rather than an open-market purchase.

When will the Elevance Health (ELV) deferred stock units be paid out to the director?

The deferred stock units will be paid in Elevance Health common stock upon the earlier of five years from the grant date or when the director leaves the board, unless she elects a later date under the Deferred Compensation Plan.

Is this Elevance Health (ELV) Form 4 transaction a market buy or sell of shares?

This Form 4 does not report a market buy or sell of Elevance Health shares. It shows a grant of 563 deferred stock units as board compensation, a non-cash equity award rather than an open-market transaction.